↓ Skip to main content

Paliperidone palmitate for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs
1 blog
twitter
10 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Paliperidone palmitate for schizophrenia
Published in
Cochrane database of systematic reviews, June 2012
DOI 10.1002/14651858.cd008296.pub2
Pubmed ID
Authors

Abraham M Nussbaum, T S Stroup

Abstract

Paliperidone palmitate, a long-acting, intramuscular formulation of paliperidone, is now available for clinical use. Paliperidone is an active metabolite of risperidone and it is also available in an oral formulation for daily use.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Ireland 1 <1%
Brazil 1 <1%
South Africa 1 <1%
Singapore 1 <1%
Unknown 147 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 19%
Researcher 22 14%
Student > Ph. D. Student 17 11%
Student > Bachelor 14 9%
Other 14 9%
Other 35 23%
Unknown 21 14%
Readers by discipline Count As %
Medicine and Dentistry 64 42%
Psychology 19 13%
Nursing and Health Professions 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Social Sciences 6 4%
Other 16 11%
Unknown 28 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2017.
All research outputs
#1,128,382
of 15,096,544 outputs
Outputs from Cochrane database of systematic reviews
#3,192
of 11,109 outputs
Outputs of similar age
#8,857
of 126,422 outputs
Outputs of similar age from Cochrane database of systematic reviews
#21
of 104 outputs
Altmetric has tracked 15,096,544 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,109 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,422 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.